128 related articles for article (PubMed ID: 30485686)
1. Recombined humanized endostatin-induced suppression of HMGB1 expression inhibits proliferation of NSCLC cancer cells.
Meng FJ; Wang S; Yan YJ; Wang CY; Guan ZY; Zhang J
Thorac Cancer; 2019 Jan; 10(1):90-95. PubMed ID: 30485686
[TBL] [Abstract][Full Text] [Related]
2. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
[TBL] [Abstract][Full Text] [Related]
3. Endostatin exerts radiosensitizing effect in non-small cell lung cancer cells by inhibiting VEGFR2 expression.
Liu L; Qiao Y; Hu C; Liu Y; Xia Y; Wang L; Liu B; Chen H; Jiang X
Clin Transl Oncol; 2016 Jan; 18(1):18-26. PubMed ID: 26542176
[TBL] [Abstract][Full Text] [Related]
4. Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549.
Li ZY; Zhu F; Hu JL; Peng G; Chen J; Zhang S; Chen X; Zhang RG; Chen LJ; Liu P; Luo M; Sun ZH; Ren JH; Huang LL; Wu G
Tumour Biol; 2011 Aug; 32(4):677-87. PubMed ID: 21442281
[TBL] [Abstract][Full Text] [Related]
5. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
Xiao P; Liu WL
Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
[TBL] [Abstract][Full Text] [Related]
6. Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of non‑small cell lung cancer cells via the HMGB1/RAGE axis and the NF‑κB/STAT3 pathway.
Liu Q; Huo Y; Zheng H; Zhao J; Jia L; Wang P
Oncol Rep; 2019 Aug; 42(2):817-825. PubMed ID: 31173265
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of recombinant human endostatin and docetaxel on human umbilical vein endothelial cells in different growth states.
Xu WJ; Huang C; Wang J; Jiang RC; Wang LC; Lin L; Liu ZJ; Sun BC; Li K
Chin Med J (Engl); 2011 Sep; 124(18):2883-9. PubMed ID: 22040497
[TBL] [Abstract][Full Text] [Related]
8. Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells.
Ma Y; Kang S; Wu X; Han B; Jin Z; Guo Z
Tumori; 2018 Oct; 104(5):338-343. PubMed ID: 28885675
[TBL] [Abstract][Full Text] [Related]
9. Endostar, a modified endostatin inhibits non small cell lung cancer cell in vitro invasion through osteopontin-related mechanism.
Ni Q; Ji H; Zhao Z; Fan X; Xu C
Eur J Pharmacol; 2009 Jul; 614(1-3):1-6. PubMed ID: 19389394
[TBL] [Abstract][Full Text] [Related]
10. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
Jiao P; Hou J; Yao M; Wu J; Ren G
Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of rh-endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh-endostatin plus pemetrexed maintenance in non-small cell lung cancer: A retrospective comparison with standard chemotherapy.
Zhou S; Zuo L; He X; Pi J; Jin J; Shi Y
Thorac Cancer; 2018 Nov; 9(11):1354-1360. PubMed ID: 30152052
[TBL] [Abstract][Full Text] [Related]
12. [Recombinant human endostatin induces apoptosis of human umbilical venous endothelial cells].
Yang F; He YL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):978-80. PubMed ID: 16864091
[TBL] [Abstract][Full Text] [Related]
13. Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis.
Yan H; Guo W; Li K; Tang M; Zhao X; Lei Y; Nie CL; Yuan Z
Exp Cell Res; 2018 Oct; 371(1):50-62. PubMed ID: 30055135
[TBL] [Abstract][Full Text] [Related]
14. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
[TBL] [Abstract][Full Text] [Related]
15. Triptolide Suppresses Growth of Breast Cancer by Targeting HMGB1 in Vitro and in Vivo.
Jiang W; Chen M; Xiao C; Yang W; Qin Q; Tan Q; Liang Z; Liao X; Mao A; Wei C
Biol Pharm Bull; 2019 Jun; 42(6):892-899. PubMed ID: 30956264
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human endostatin inhibits TNF-alpha-induced receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes in mice with adjuvant arthritis.
Gao QF; Zhang XH; Yuan FL; Zhao MD; Li X
Cell Biol Int; 2016 Dec; 40(12):1340-1348. PubMed ID: 27730697
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness.
Liu PL; Tsai JR; Hwang JJ; Chou SH; Cheng YJ; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
Am J Respir Cell Mol Biol; 2010 Nov; 43(5):530-8. PubMed ID: 19933377
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effects of recombinant human endostatin on the metastatic potential and invasiveness of hepatocellular carcinoma HCCLM6 cells in vitro].
Zhang PH; Qin J; Li AM; Ding XM; Yang-feng D; Rong-cheng L
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):658-61. PubMed ID: 18495614
[TBL] [Abstract][Full Text] [Related]
19. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
20. Pectolinarigenin inhibits non‑small cell lung cancer progression by regulating the PTEN/PI3K/AKT signaling pathway.
Xu F; Gao X; Pan H
Oncol Rep; 2018 Dec; 40(6):3458-3468. PubMed ID: 30542737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
